SNY » Topics » May 31, 2006 (after the end of the Shareholders Annual General Meeting)

This excerpt taken from the SNY 20-F filed Mar 7, 2008.

May 31, 2007 (after the end of the Shareholders’ Annual General Meeting)



update on Plavix®



proposed acquisition



share repurchase program, delegation of powers to the Chief Executive Officer

This excerpt taken from the SNY 20-F filed Apr 3, 2007.

May 31, 2006 (after the end of the Shareholders’ Annual General Meeting)



resignation of Hermann Scholl as a director



share repurchase program: delegation of powers to the Chairman and Chief Executive Officer



authorizations/delegations of powers relating to sureties, endorsements and guarantees


Mar 7, 2008
Apr 3, 2007
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki